|
|
|
| home > ebr > spring 2003 > biotech companies in the pharma market - grow or be doomed, warns dr volker janssen, director at simon-kucher & partners |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review
|
| The German biotech industry is booming. According to a study carried out by management consultancy Ernst & Young, the number of biotech companies with less than 500 employees (this accounts for the majority of German biotechs) increased by more than 90 per cent between 1997 and 2000, which means there are now more than 300 biotech companies operating in Germany. The turnover generated by these companies has nearly tripled, as has the number of employees. In 2000, the Biotech Index on the Neuer Markt in Frankfurt was often quoted at 50 per cent above the NEMAX Allshare Index. In view of Germany's unparalleled growth in the biotech arena one was inclined to believe Deutsche Bank's forecasts for the sector: a turnover increase for SME |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Dr Volker Janssen, Director at Simon-Kucher & Partners
Dr Volker Janssen is a Director in the Life Science division of Simon-Kucher & Partners Strategy & Marketing Consultants. He specialises in consulting to pharmaceutical clients, mainly in the areas of strategic marketing, corporate communications, sales force management, market segmentation, international pricing and value-to-customer.
He has worked for a number of companies in Europe, Japan and the US, including Aventis, Pfizer, Novo Nordisk, Fujisawa, Johnson & Johnson, Eli Lilly, 3M, Sanitec and DHL. Dr Janssen is the author of numerous publications on pricing, sales force management and communication and has spoken frequently at conferences and seminars on these subjects.
|
|
|
|
|
|
 |
Industry Events |
 |
EMBALLAGE 2012
19-22 November 2012, Paris Nord Villepinte, France
EMBALLAGE has clearly delineated sectors to make the decision-maker’s task easier when visiting and to highlight all the industry’s know-how: machinery and packaging for the food and cosmetics sectors, health solutions and luxury packaging and containers, etc. Hence, EMBALLAGE provides a bespoke solution for each industry
More info >> |
|
 |
News and Press Releases |
 |
Prism Ideas and dMetrics Launch Pioneering Service Analysing Patient–Reported Action, Behaviours and Outcomes with Social Media
Prism Ideas, the multi-national medical marketing and drug development consultants, today announced its collaboration with dMetrics, experts in identifying decisions made by millions of patients online, to launch a pioneering analysis service to evaluate patient healthcare outcomes reported within social media. Combining expertise in language analytics and healthcare, the two companies are interrogating social media to determine patient actions and insights, profiling patient needs, symptoms and response to treatment.
More info >> |
|
|
